Alcedis Platforms: The Path to Decentralized Clinical Trials

^{Created: 03.24.2023}

 

As a digital full-service CRO, Alcedis drives the digitalization of clinical research to enable more efficient and patient-centered trial execution. With the Alcedis Platforms technology and service platform, science, technologies, and innovations are combined to optimize decentralized clinical trials and digital clinical trials. From vision to solution – the path to Alcedis Platforms.

 

The Vision of Alcedis Platforms for Digital and Decentralized Clinical Trials

Digitalization is fundamentally transforming clinical research: A wide range of digital solutions, from the integration of apps and devices to big-data analysis and machine learning, offers new opportunities for clinical trials. Decentralized clinical trials particularly benefit from these digital developments:

• Real-time data collection – directly from patients at home or on the go

• Patient care through digital services such as mobile apps

• Analysis of large datasets using artificial intelligence

The increasing complexity of clinical trials requires innovative approaches. Study leaders face challenges in efficiently integrating technological innovations and digital services. Instead of many isolated single solutions, Alcedis Platforms follows the approach of bundling all relevant data flows and processes of a clinical trial into one system. The goal is to optimize digital and decentralized clinical trials and drive the digitalization of research.

 

Challenges in Developing Alcedis Platforms

Alcedis relies on a strong network of CROs and service providers that successfully conduct trials worldwide. With Alcedis Platforms, the company goes one step further: The platform integrates various data sources and software solutions to enable the execution of digital and decentralized clinical trials. These include:

• Mobile apps

• Wearable devices

• Digital databases

• Software-based services

The biggest challenge was the seamless integration of these digital solutions. A key solution was the development of a REST API, which provides a standardized connection between all relevant data sources. The Clinical Trial Management System (CTMS) serves as the core of the platform, ensuring a structured and transparent execution of decentralized clinical trials.

 

Digital Clinical Trials with Alcedis Platforms

Through strategic partnerships and continuous technological advancements, Alcedis Platforms meets the individual requirements of digital and decentralized clinical trials. Alcedis acts not only as a CRO but also as an innovator and consultant for cutting-edge solutions. Data protection and security are always at the forefront: Patient data is processed in compliance with all international security standards, and role-based access controls ensure the secure handling of sensitive information.

Furthermore, the digital services provided by Alcedis Platforms contribute to improving patients' health and medical care in the long term. Even after the completion of a clinical trial, patients often retain access to digital solutions to continue benefiting from their features.

 

Alcedis Platforms: The Future of Digital and Decentralized Clinical Trials

Alcedis is already setting new standards in real-world data collection. One example is the European Melanoma Registry (EuMelaReg), which collects real-world data from skin cancer patients across Europe. Such big-data projects could serve as benchmarks in digital clinical trials in the future.

Digital and decentralized clinical trials are the future of research. Alcedis Platforms is actively shaping this transformation: as a platform that offers digital innovations and integrates them individually into trials. This enables Alcedis to successfully conduct new, patient-centered clinical trials.